| Autophagy and Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Implications |
62 |
| The Physiological Roles of Amyloid-beta Peptide Hint at New Ways to Treat Alzheimer's Disease |
58 |
| Corroboration of a Major Role for Herpes Simplex Virus Type 1 in Alzheimer's Disease |
50 |
| Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities |
38 |
| Role of Tau as a Microtubule-Associated Protein: Structural and Functional Aspects |
38 |
| Microglia in Alzheimer's Disease: Activated, Dysfunctional or Degenerative |
35 |
| Astrocyte Heterogeneity: Impact to Brain Aging and Disease |
35 |
| Lipopolysaccharide Associates with Amyloid Plaques, Neurons and Oligodendrocytes in Alzheimer's Disease Brain: A Review |
35 |
| Deciphering the Astrocyte Reaction in Alzheimer's Disease |
34 |
| Flavonoids as Prospective Neuroprotectants and Their Therapeutic Propensity in Aging Associated Neurological Disorders |
33 |
| Weight Loss and Malnutrition in Patients with Parkinson's Disease: Current Knowledge and Future Prospects |
32 |
| Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease |
32 |
| High Cortisol and the Risk of Dementia and Alzheimer's Disease: A Review of the Literature |
31 |
| Role of Copper in the Onset of Alzheimer's Disease Compared to Other Metals |
29 |
| Can an Infection Hypothesis Explain the Beta Amyloid Hypothesis of Alzheimer's Disease? |
28 |
| Cerebrovascular Smooth Muscle Cells as the Drivers of Intramural Periarterial Drainage of the Brain |
28 |
| The Role of APOE4 in Disrupting the Homeostatic Functions of Astrocytes and Microglia in Aging and Alzheimer's Disease |
27 |
| Recent Advances in Biomarkers for Parkinson's Disease |
27 |
| Deep Learning in Alzheimer's Disease: Diagnostic Classification and Prognostic Prediction Using Neuroimaging Data |
26 |
| The Aerobic and Cognitive Exercise Study (ACES) for Community-Dwelling Older Adults With or At-Risk for Mild Cognitive Impairment (MCI): Neuropsychological, Neurobiological and Neuroimaging Outcomes of a Randomized Clinical Trial |
25 |
| NSAID Exposure and Risk of Alzheimer's Disease: An Updated Meta-Analysis From Cohort Studies |
25 |
| New Perspectives on Roles of Alpha-Synuclein in Parkinson's Disease |
24 |
| Molecular Mechanisms for Herpes Simplex Virus Type 1 Pathogenesis in Alzheimer's Disease |
23 |
| Astrocytes and Aging |
23 |
| A Nonlinear Simulation Framework Supports Adjusting for Age When Analyzing BrainAGE |
23 |
| A Critical Role of Autophagy in Regulating Microglia Polarization in Neurodegeneration |
22 |
| Dysfunctional Mitochondria and Mitophagy as Drivers of Alzheimer's Disease Pathogenesis |
21 |
| Dysfunction of Cerebrovascular Endothelial Cells: Prelude to Vascular Dementia |
21 |
| Relevance of Phosphorylation and Truncation of Tau to the Etiopathogenesis of Alzheimer's Disease |
20 |
| Tau Phosphorylation Rates Measured by Mass Spectrometry Differ in the Intracellular Brain vs. Extracellular Cerebrospinal Fluid Compartments and Are Differentially Affected by Alzheimer's Disease |
20 |
| Phytochemical and Pharmacological Role of Liquiritigenin and Isoliquiritigenin From Radix Glycyrrhizae in Human Health and Disease Models |
19 |
| Exosome Determinants of Physiological Aging and Age-Related Neurodegenerative Diseases |
19 |
| Neuroinflammation and the Gut Microbiota: Possible Alternative Therapeutic Targets to Counteract Alzheimer's Disease? |
19 |
| Executive Functions in Alzheimer Disease: A Systematic Review |
19 |
| The Aging of Iron Man |
19 |
| The Relation Between Brain Amy o d Deposition, Cortical Atrophy, and Plasma Biomarkers in Amnesic Mild Cognitive Impairment and Alzheimer's Disease |
18 |
| MicroRNA-455-3p as a Potential Biomarker for Alzheimer's Disease: An Update |
18 |
| Insulin Signaling Impairment in the Brain as a Risk Factor in Alzheimer's Disease |
18 |
| Dopamine and Dopamine Receptors in Alzheimer's Disease: A Systematic Review and Network Meta-Analysis |
18 |
| Increased DJ-1 and alpha-Synuclein in Plasma Neural-Derived Exosomes as Potential Markers for Parkinson's Disease |
17 |
| Reduced Regional Cerebral Blood Flow Relates to Poorer Cognition in Older Adults With Type 2 Diabetes |
17 |
| Systemic Inflammation Mediates Age-Related Cognitive Deficits |
17 |
| Thinking While Moving or Moving While Thinking - Concepts of Motor-Cognitive Training for Cognitive Performance Enhancement |
17 |
| The Early Events That Initiate beta-Amyloid Aggregation in Alzheimer's Disease |
17 |
| Microglia Polarization, Gene-Environment Interactions and Wnt/beta-Catenin Signaling: Emerging Roles of Glia-Neuron and Glia-Stem/Neuroprogenitor Crosstalk for Dopaminergic Neurorestoration in Aged Parkinsonian Brain |
16 |
| Radiomic Features of Hippocampal Subregions in Alzheimer's Disease and Amnestic Mild Cognitive Impairment |
16 |
| Brain Network Modularity Predicts Exercise-Related Executive Function Gains in Older Adults |
16 |
| Phyto-Therapeutic and Nanomedicinal Approaches to Cure Alzheimer's Disease: Present Status and Future Opportunities |
16 |
| TREM2 in Alzheimer's Disease: Microglial Survival and Energy Metabolism |
16 |
| Effects of Virtual Reality-Based Physical and Cognitive Training on Executive Function and Dual-Task Gait Performance in Older Adults With Mild Cognitive Impairment: A Randomized Control Trial |
16 |
